The Medici is a new organization which aims to drive progress and innovation in the understanding and treatment of blood cancers, through the exchange of ideas and the pursuit of excellence in research and development.
"By developing and patenting the first predictive thera-nostic biomarker profile in the field of Multiple Myeloma we have opened the door to personalising patient therapies to maximise patient response rates to treatment of all Blood Cancers" . Professor Peter O'Gorman